Aktiesnakken — November 2010
-
Det vil være en meget stor overraskelse hvis merck ikke filer på grazax i USA indenfor meget kort tid.
-
ALK er en rigtig interessant case i forhold til netop grazax i US
-
Det kan komme til at blive en meget kraftig vækstmotor for dem i de kommende år
-
masha det må du gerne uddybe. Hvorfor skulle Merck vente med at file for et stof
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

og Bager henviser hele tiden til Merck - som om han end ikke er informeret?